| Financial Year |
March 31 2023 |
| Monetary Funds |
227,024,343.81 |
| Held-for-trading Financial Assets |
77,000,000.00 |
| Notes Receivable |
56,283,549.01 |
| Accounts Receivable |
898,121,742.62 |
| Advances to Suppliers |
55,821,178.28 |
| Other Receivables |
44,023,105.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,019,791.95 |
| Dividend Receivable |
-- |
| Inventories |
390,486,382.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,003,067.88 |
| Total Current Assets |
1,993,509,299.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
584,618,127.93 |
| Under-construction Projects |
9,034,647.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
131,781,537.32 |
| R&D expenses |
-- |
| Goodwill |
382,703,786.49 |
| Long-Term Deferred and Prepaid Expenses |
13,059,993.24 |
| Deferred Income Tax Assets |
44,163,937.94 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,174,535,432.46 |
| Total Assets |
3,168,044,732.41 |
| Short-Term Loans |
259,778,700.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
209,509,195.20 |
| Accounts Payable |
594,081,682.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,670,146.15 |
| Taxes Payable |
13,258,458.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,893,303.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
227,360,000.00 |
| Other Current Liabilities |
65,325,989.30 |
| Sub-Total of Current Liabilities |
1,515,702,787.10 |
| Long-term Loans |
558,228,120.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
38,282,756.68 |
| Deferred Income Tax Liabilities |
196,413.20 |
| Other Non-Current Liabilities |
205,496,888.90 |
| Sub-Total of Non-Current Liabilities |
812,791,634.64 |
| Total Liabilities |
2,328,494,421.74 |
| Paid-In Capital(Or Share Stock) |
333,145,932.00 |
| Capital Surplus |
284,374,799.38 |
| Surplus Reserve |
61,779,202.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
85,461,645.02 |
| Minority Stockholder's Interest |
87,198,732.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
752,351,578.55 |
| Owner's Equity（Stockholder's Equity） |
839,550,310.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,168,044,732.41 |
